Treatment for hepatitis C virus‐associated cryoglobulinaemic vasculitis
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
This review aims to look at the benefits and harms of the currently available treatment options to treat the HCV‐associated cryoglobulinaemic vasculitis with active manifestations of vasculitis (cutaneous or glomerulonephritis).